Adaptive Biotechnologies Corp (ADPT) stock
ADPTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/30322% above fair value
$29.04−0.44 (-1.49%)
Close on Nov 13, 2026Market cap $4.63BP/E –Yield –
Adaptive Biotechnologies statistics
84 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 4, 2027 (estimated, after the close)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 81.62
- 2.22
Enterprise valuationIndustry
- EV / Sales
- 14.57
- 2.57
Share statisticsIndustry
- Shares Change (YoY)
- 7.07%
- 10.8%
- Shares Change (QoQ)
- 1.58%
- 0.50%
- Float
- 123M
- 49M
- Shares Held by Insiders
- 22.7%
- 11.7%
- Shares Held by Institutions
- 97.6%
- 56.4%
Short sellingIndustry
- Short Interest
- 11M
- –
- Short Interest Change
- -4.28%
- -0.80%
- Short % of Float
- 9.30%
- 9.01%
- Short % of Shares Outstanding
- 7.19%
- 6.30%
- Days to Cover
- 6.07
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $32.21
- –
- 52-Week Low
- $12.00
- –
- 20-Day Moving Average
- $27.06
- –
- 50-Day Moving Average
- $26.91
- –
- 200-Day Moving Average
- $20.09
- –
- Average True Range (14)
- $1.76
- –
- Price Change (1 Week)
- 3.79%
- -1.15%
- Price Change (1 Month)
- 13.5%
- -4.87%
- Price Change (3 Months)
- 17.2%
- -21.0%
- Price Change (6 Months)
- 126.3%
- -20.6%
- Price Change (YTD)
- 78.8%
- -23.6%
- Price Change (1 Year)
- 100.3%
- -22.4%
- Price Change (3 Years)
- 610.0%
- -29.5%
- Price Change (5 Years)
- -12.6%
- -77.9%
- Average Volume (10 Days)
- 2M
- –
- Average Volume (20 Days)
- 2M
- –
- Average Volume (90 Days)
- 2M
- –
- Relative Volume
- 0.89
- 0.70
- Relative Strength Index (14)
- 57.5
- 43.4
- Volatility (1 Year)
- 66.7%
- 80.1%
- Beta (5 Years)
- 1.78
- 1.07
MarginsIndustry
- EBITDA Margin
- -16.2%
- -27.7%
- FCF Margin
- -2.96%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- -37.1%
- -49.9%
- Return on Assets (ROA)
- -12.0%
- -40.6%
- Return on Invested Capital (ROIC)
- -9982.4%
- -32.9%
- Return on Capital Employed (ROCE)
- -8.25%
- -37.9%
Financial positionIndustry
- Current Ratio
- 3.97
- 3.30
- Quick Ratio
- 3.69
- 2.39
- Debt / Equity
- 0.00
- 0.49
- Interest Coverage
- -5.33
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- 17.9%
- 6.82%
- Revenue Growth (3Y CAGR)
- 14.3%
- 2.25%
- Revenue Growth (5Y CAGR)
- 23.0%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.51
- 0.40
- Inventory Turnover
- 7.71
- 2.73
- Revenue Per Employee
- $477.58K
- $429.29K
- Profits Per Employee
- -$113.02K
- -$689.41K
- Employee Count
- 624
- 74
- WACC
- 14.0%
- 10.2%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $298.95M
- $17.76M
- Net Cash Per Share
- $1.87
- $0.80
- Equity (Book Value)
- $176.21M
- $53.89M
- Book Value Per Share
- $1.10
- $1.50
- Tangible Book Value
- $56.79M
- $27.13M
- Working Capital
- $293.72M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$4.55M
- -$1.00M
- FCF Per Share
- -$0.06
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -1.52%
- -21.8%
- FCF Yield
- -0.19%
- -9.44%
Taxes and interestIndustry
- Interest Expense
- $9.04M
- $2.90M
Scores and fair valueIndustry
- Altman Z-Score
- 3.38
- 0.23
- Piotroski F-Score
- 5
- 4
- Beneish M-Score
- -2.42
- -2.63
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | ADPT | S&P 500 | Difference | ADPT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +14.9% | -3.0% | +17.9 pts | ||
| 3 months | +18.7% | -2.8% | +21.5 pts | ||
| Year to date | +78.8% | +11.5% | +67.3 pts | ||
| 1 year | +105.4% | +13.5% | +91.9 pts | ||
| 3 years | +740.5% | +77.7% | +662.8 pts | +103.3% | +21.1% |
| 5 years | -12.6% | +72.6% | −85.2 pts | -2.6% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
11M ADPT shares were sold short on Oct 30, 2026, down 4.3% from the previous report, or 9.30% of the shares available to trade. At recent volumes it would take 6.1 days to buy them back. Over the last 20 sessions, 47.2% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 11,478,831 | -4.3% | 1,889,527 | 6.1 |
| Oct 15, 2026 | 11,991,988 | +1.3% | 2,383,521 | 5.0 |
| Sep 30, 2026 | 11,843,887 | -12.2% | 2,674,025 | 4.4 |
| Sep 15, 2026 | 13,489,581 | +15.2% | 1,708,828 | 7.9 |
| Aug 31, 2026 | 11,712,796 | -12.1% | 1,839,973 | 6.4 |
| Aug 14, 2026 | 13,323,767 | +6.7% | 2,329,412 | 5.7 |
| Jul 31, 2026 | 12,490,395 | +9.6% | 2,844,419 | 4.4 |
| Jul 15, 2026 | 11,396,387 | +0.4% | 2,645,741 | 4.3 |
| Jun 30, 2026 | 11,352,839 | +48.5% | 5,086,171 | 2.2 |
| Jun 15, 2026 | 7,645,147 | -7.2% | 2,708,847 | 2.8 |
| May 29, 2026 | 8,240,744 | -7.4% | 1,606,754 | 5.1 |
| May 15, 2026 | 8,897,341 | +5.4% | 1,955,224 | 4.5 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?